Be mindful of meal timing
As a GLP-1 receptor agonist, Ozempic is gaining increasing recognition for its superior effectiveness in supporting patients weight management journeys and helping them attain healthier lifestyles
In January of this year, the FDA noted that it had "received adverse event reports after patients used compounded semaglutide" and that "patients should not use a compounded drug if an approved drug is available to treat a patient." In July, the agency followed up with a notice that it had "received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products." And in August, Eli Lilly, the maker of Zepbound and Mounjaro, sent a series of cease-and-desist letters to providers urging them to stop prescribing compounded versions of those drugs
For women who haven't been able to reach their weight goals through diet and exercise alone, GLP-1 medications are one option a healthcare professional, such as a Midi Health clinician, may recommend as part of a broader weight management plan
Starting Weight 220-280 lbs Higher starting weights often experience a more gradual onset of side effects
[DOI] [PubMed] [Google Scholar] 6